FDA Committee Rejects MDMA Therapy for PTSD Due to Risk-Benefit Concerns
On Tuesday, an FDA advisory committee found that MDMA, commonly known as ecstasy, is not an effective treatment for post-traumatic stress disorder, voting that the combination of therapy